AVTX - Avalo Therapeutics Inc
IEX Last Trade
7
-2.050 -29.286%
Share volume: 71,448
Last Updated: Fri 30 Aug 2024 09:59:24 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$9.05
-2.05
-22.65%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-04 | 2022-11-07 | 2023-03-29 | 2023-05-04 | 2023-08-03 | 2023-11-09 | 2024-03-29 | 2024-05-13 | |
Cash flow financing | -14.781 M | 0.000 | 82.000 K | 13.748 M | 598.000 K | 10.695 M | 1.000 K | 108.612 M | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cash flow | -12.470 M | 5.726 M | -3.940 M | -10.052 M | -11.026 M | -6.836 M | -2.766 M | -6.202 M | |
Net income | -12.987 M | 3.192 M | -9.812 M | -9.955 M | -8.193 M | -5.228 M | -8.168 M | -121.290 M | |
Depreciation | 30.000 K | 34.000 K | 35.000 K | 33.000 K | 41.000 K | 41.000 K | 43.000 K | 34.000 K | |
Changes in inventories | 23.000 K | 22.000 K | 20.000 K | 19.000 K | 18.000 K | 0.000 | 0.000 | 0.000 | |
Changes in receivables | 544.000 K | 0.000 | 0.000 | 0.000 | 38.000 K | 0.000 | 0.000 | 0.000 | |
Investing Cashflow | -56.000 K | -39.000 K | 0.000 | -133.000 K | 0.000 | 0.000 | 0.000 | 356.000 K | |
Net Borrowings | 4.273 M | -309.000 K | 3.035 M | 595.000 K | 6.667 M | -12.658 M | -8.394 M | -111.209 M | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | -56.000 K | -39.000 K | 0.000 | 0.000 | 0.000 | 0.000 | -158.000 K | 0.000 | |
Cash Change | 11.249 M | 16.943 M | 13.172 M | 16.687 M | 6.307 M | 10.180 M | 7.415 M | 110.177 M |